IRIS
DE VITA, Ferdinando
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 16.575
NA - Nord America 10.535
AS - Asia 6.689
SA - Sud America 1.061
Continente sconosciuto - Info sul continente non disponibili 603
AF - Africa 91
OC - Oceania 13
Totale 35.567
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.207
RU - Federazione Russa 9.985
SG - Singapore 2.341
IE - Irlanda 1.735
CN - Cina 1.434
IT - Italia 1.396
HK - Hong Kong 1.027
BR - Brasile 879
VN - Vietnam 778
UA - Ucraina 763
GB - Regno Unito 721
DE - Germania 621
FR - Francia 412
KR - Corea 389
FI - Finlandia 321
SE - Svezia 216
CA - Canada 207
IN - India 179
TR - Turchia 147
JP - Giappone 138
GR - Grecia 137
AR - Argentina 59
BD - Bangladesh 48
NL - Olanda 47
AT - Austria 46
MX - Messico 44
PL - Polonia 42
ID - Indonesia 39
BE - Belgio 33
EC - Ecuador 30
IQ - Iraq 27
ES - Italia 23
ZA - Sudafrica 22
PK - Pakistan 21
CL - Cile 18
CO - Colombia 18
VE - Venezuela 18
CR - Costa Rica 17
MA - Marocco 14
PE - Perù 14
SC - Seychelles 13
JM - Giamaica 12
SA - Arabia Saudita 12
CZ - Repubblica Ceca 11
LT - Lituania 11
AL - Albania 10
PH - Filippine 10
IL - Israele 9
PY - Paraguay 9
TH - Thailandia 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
BO - Bolivia 8
HN - Honduras 8
DO - Repubblica Dominicana 7
EE - Estonia 7
KZ - Kazakistan 7
NP - Nepal 7
NZ - Nuova Zelanda 7
PT - Portogallo 7
TN - Tunisia 7
UY - Uruguay 7
AU - Australia 6
AZ - Azerbaigian 6
EG - Egitto 6
IR - Iran 6
KE - Kenya 6
MY - Malesia 6
DK - Danimarca 5
EU - Europa 5
JO - Giordania 5
LB - Libano 5
SN - Senegal 5
SV - El Salvador 5
TT - Trinidad e Tobago 5
GT - Guatemala 4
PR - Porto Rico 4
RO - Romania 4
CG - Congo 3
ET - Etiopia 3
KG - Kirghizistan 3
LU - Lussemburgo 3
LV - Lettonia 3
NI - Nicaragua 3
RS - Serbia 3
TW - Taiwan 3
AG - Antigua e Barbuda 2
AO - Angola 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
BY - Bielorussia 2
CY - Cipro 2
DZ - Algeria 2
HU - Ungheria 2
LK - Sri Lanka 2
MK - Macedonia 2
OM - Oman 2
PA - Panama 2
QA - Qatar 2
Totale 34.943
Salva come PNG Salva come JPEG
Città #
Moscow 3.641
Dublin 1.726
San Jose 1.264
Jacksonville 1.178
Santa Clara 1.033
Hong Kong 1.015
Singapore 929
Chandler 805
Ashburn 792
Council Bluffs 590
Seoul 373
Princeton 247
Ho Chi Minh City 239
Medford 216
New York 209
Milan 206
Hanoi 186
Beijing 172
Hefei 168
Naples 165
Caserta 145
Ann Arbor 142
Boardman 142
Roxbury 141
Bremen 134
San Mateo 125
Bengaluru 122
Helsinki 116
Los Angeles 103
Munich 100
Elora 97
Wilmington 97
Dallas 92
Woodbridge 75
São Paulo 69
The Dalles 66
Nanjing 65
Des Moines 53
Rome 53
Dong Ket 52
Cambridge 51
Nuremberg 49
Napoli 46
Chicago 45
Miano 42
Jinan 37
Da Nang 36
North Charleston 35
Atlanta 31
Houston 31
Mountain View 30
Rio de Janeiro 30
Haiphong 27
Amsterdam 26
Kraków 26
Tokyo 26
Brussels 25
Tianjin 24
Vienna 24
Belo Horizonte 23
Toronto 23
Orem 22
Las Vegas 21
North Bergen 21
Norwalk 21
Curitiba 20
Montreal 20
Memphis 19
Aversa 18
Hangzhou 18
Phoenix 18
Turku 18
Zhengzhou 18
Biên Hòa 17
Shanghai 17
Brasília 16
Changsha 16
Düsseldorf 16
San Francisco 16
Shenyang 16
Brooklyn 15
Chennai 15
Guangzhou 15
Jakarta 15
Aiello Del Sabato 14
Hải Dương 14
Frankfurt am Main 13
London 13
Nanchang 13
Ottawa 13
Philadelphia 13
San José 13
Thái Nguyên 13
Auburn Hills 12
Cleveland 12
Guarulhos 12
Manchester 12
Thái Bình 12
Buffalo 11
Hillsboro 11
Totale 18.439
Salva come PNG Salva come JPEG
Nome #
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis 221
Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy. 218
ONCOLOGIA MEDICA 215
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients 203
MicroRNA-423-5p promotes autophagy in cancer cells and is increased in serum from hepatocarcinoma patients treated with sorafenib 201
Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience 200
Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis 198
Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma—a pilot study. Curr Oncol 21, 3, june 2014 125-133 198
Small bowel metastasis from pancreatic cancer in a long-term survival patient with synchronous advanced malignant pleural mesothelioma: A case report and literature review 195
Adjuvant chemoradiotherapy in patients with stage III-IV radically resected gastric cancer: a pilot study 195
A possible connective tissue primary lymphoepithelioma-like carcinoma (LELC). 191
A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer 190
Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: A propensity score-matched analysis 190
A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant 190
Microsatellite Status Detection in Gastrointestinal Cancers: PCR/NGS Is Mandatory in Negative/Patchy MMR Immunohistochemistry 190
Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis 188
Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors 186
Amifostine: a selective cytoprotective agent of normal tissues from chemo-radiotherapy induced toxicity (Review) 185
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study) 183
CD 26-positive/CD 326-negative circulating cancer cells as prognostic markers for colorectal cancer recurrence 181
Comparison of the current AJCC-TNM numeric-based with a new anatomical location-based lymph node staging system for gastric cancer: A western experience 179
Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitors. 177
Clinical management of advanced gastric cancer: Role of new molecular drugs. 176
Analysis of neurothelin expression in neoplastic cells derived from gastrointestinal tract tumors 176
A true splenic cyst producing carboydrate antigen 19-9 and cancer antigen 50 and 125,but not interleukin 10 175
Antitumor activity of ZD6474, a vascular endothelial growth factor-2 and epidermal growth factor receptor small molecule tyrosine kinase inhibitor, in combination with SC-236, a cyclooxygenase-2 inhibitor 173
Different Biomarkers address different colorectal cancer stem cell populations: who's the killer? 172
Liquid Biopsy at Home: Delivering Precision Medicine for Patients with Cancer During the Covid-19 Pandemic 172
Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma. 171
Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survival 170
Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial 169
Pancreatic fistula following pancreatoduodenectomy. Evaluation of different surgical approaches in the management of pancreatic stump. Literature review. 169
A true splenic cyst producing carbohydrate antigen 19-9 and cancer antigens 50 and 125, but not interleukin 10 169
Combined CD133/CD44 Expression as a Prognostic Indicator of Disease-Free Survival in Patients With Colorectal Cancer. 169
Behavior of circulating CD4+CD25+FOXP3* regulatory T cells in colon cancer patients undergoing surgery 169
Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC 169
Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment 168
Naples Prognostic Score Predicts Tumor Regression Grade in Resectable Gastric Cancer Treated with Preoperative Chemotherapy 168
Treatment of gastric cancer. 165
antitumor activity of zd6474, a VEGFR-2 and EGFR small molecule tyrosine kinase inhibitor in combination with SC-236, a cicloxigenase-2 inhibitor 165
DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer 163
Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer 162
An intramedullary "flame" recognized as being an intramedullary spinal cord metastasis from esophageal cancer 162
Novel Therapeutic Opportunities in Neoadjuvant Setting in Urothelial Cancers: A New Horizon Opened by Molecular Classification and Immune Checkpoint Inhibitors 162
Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review. 161
Conversion chemotherapy followed by epatic resection in colorectal cancer with initially unresectable liver-limited metastases 161
Immunotherapy in Penile Squamous Cell Carcinoma: Present or Future? Multi-Target Analysis of Programmed Cell Death Ligand 1 Expression and Microsatellite Instability 160
Predictive biomarkers along gastric cancer pathogenetic pathways 160
Discrepancy of p16 immunohistochemical expression and HPV RNA in penile cancer. A multiplex in situ hybridization/immunohistochemistry approach study 159
Analysis of interleukin-2/interleukin-2 receptor system in advanced non-small-cell lung cancer 158
Adult Wilms' tumor: a case report 158
Adjuvant Treatment in Pancreatic Cancer: Shaping the Future of the Curative Setting 158
Inflammatory and nutritional status is a predictor of long-term outcome in patients undergoing surgery for gastric cancer. Validation of the Naples prognostic score. 157
Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: relationship with radicality and outcome 156
A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases. 156
Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer 156
HER2-Low Status Does Not Affect Survival Outcomes of Patients with Metastatic Breast Cancer (MBC) Undergoing First-Line Treatment with Endocrine Therapy plus Palbociclib: Results of a Multicenter, Retrospective Cohort Study 155
Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy 155
Anthracycline-induced cardiotoxicity: monitoring and prevention of the lesion 154
Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors 153
A rare case of extraovarian primary peritoneal carcinoma in a 72 year-old woman 153
Correlation between efficacy and skin rash occurrence following treatment with the epidermal growth factor receptor inhibitor cetuximab: a single institution retrospective analysis 153
Is complete mesocolic excision with central vascular ligation safe and effective in the surgical treatment of right-sided colon cancers ? A prospective study. 153
Clinical efficacy of sequential treatments in KRASG12C-mutant metastatic colorectal cancer: findings from a real-life multicenter Italian study (CRC-KR GOIM) 152
Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAF wild-type metastatic colorectal cancer in the CAPRI 2-GOIM trial 152
Neutrophil to lymphocyte ratio is a strong predictor of tumor recurrence in early colon cancers: a propensity score-matched analysis 152
Clinical practice use of liquid biopsy to identify RAS/BRAF mutations in patients with metastatic colorectal cancer (mCRC): A single institution experience 152
Identification of Tissue miRNA Signatures for Pancreatic Ductal Adenocarcinoma 151
Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: A randomised study by the Southern Italy Cooperative Oncology Group 151
The over-the-scope-clip (OTSC) system is effective in the treatment of chronic esophago-jejunal anastomotic leakage 151
Panitumumab plus trifluridine/tipiracil as anti‐EGFR rechallenge therapy in patients with refractory RAS wild‐type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trial 149
Farmacogenomica e cancro colorettale 148
Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugs 148
Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial 147
Implementation of BRCA mutations testing in formalin-fixed paraffin-embedded (FFPE) samples of different cancer types 147
Hepatoid carcinoma colliding with a liposarcoma of the left colon serosa presenting as an abdominal mass 147
Triple-Negative Breast Cancers: Systematic Review of the Literature on Molecular and Clinical Features with a Focus on Treatment with Innovative Drugs 147
Analysis of recovery time indexes in 5-fluorouracil-treated cancer patients 146
Synergistic Antitumor Activity of Sorafenib in Combination with Epidermal Growth Factor Receptor Inhibitors in Colorectal and Lung Cancer Cells 144
PERSPECTIVES OF THE NEOADJUANT THERAPY IN ADVANCED ESOPHAGEAL CARCINOMA 144
Atypycal presentation of Merkel cell carcinoma positive to polyomavirus DNA detection: experience from a single center 144
Pattern of recurrence and overall survival in esophagogastric cancer after perioperative FLOT and clinical outcomes in MSI-H population: the PROSECCO Study 143
Adjuvant chemotherapy of gastric cancer: which regimen? 142
Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies 142
Serum interleukin-10 is an independent prognostic factor in advanced solid tumors 142
p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate 142
Immune-Based Therapy in Triple-Negative Breast Cancer: From Molecular Biology to Clinical Practice 141
Assessment of the DNA Mismatch Repair System Is Crucial in Colorectal Cancers Necessitating Adjuvant Treatment: A Propensity Score-Matched and Win Ratio Analysis 141
Complete response to preoperative chemoradiation and survival in esophageal cancer : a pooled analysis of three singe-institution phase II trials. 141
TRASTUZUMAB RESISTANCE IN BREAST CANCER 141
Presence of tumor deposits is a strong indicator of poor outcome in patients with stage III colorectal cancers undergoing radical surgery 140
Increased circulating levels of vascular endothelial growth factor C can predict outcome in resectable gastric cancer patients 140
The lymph node ratio is a powerful prognostic factor of node-positive colon cancers undergoing potentially curative surgery. 139
Vertebral carcinomatosis eleven years after advanced gastric cancer resection: A case report. 139
Cardiotossicità da antracicline: attualità e prospettive 139
PROSPETTIVE DELLA TERAPIA NEOADIUVANTE NEL CANCRO ESOFAGEO AVANZATO 139
Serum vascular endothelial growth factor (VEGF)levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer 137
Chemoradiotherapy as adjuvant treatment of gastric cancer 137
Integrated therapy in localized gastric cancer: targeted and tailored approach. 136
TRATTAMENTO MULTIMODALE DEL CA ESOFAGEO. NOSTRA ESPERIENZA 136
Totale 16.293
Salva come PNG Salva come JPEG
Categoria #
all - tutte 123.813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.813
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.293 0 0 0 24 528 8 29 48 51 61 125 419
2022/20233.327 429 61 45 262 363 256 15 194 1.587 14 55 46
2023/20241.307 107 36 59 117 444 166 11 31 16 19 95 206
2024/20253.993 37 109 38 110 618 512 491 367 567 549 306 289
2025/202617.073 593 826 815 843 1.354 9.303 792 931 722 435 233 226
2026/20273.338 235 478 1.368 1.257 0 0 0 0 0 0 0 0
Totale 35.567